Wyndham H Wilson, M.D.
National Cancer Institute (NCI) · National Cancer Institute, National Institutes of Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wyndham H Wilson, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:50 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01445535 · Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasNational Cancer Institute (NCI) · completed · T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma · principal investigator
- Ph1/Ph2NCT01415765 · MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaNational Cancer Institute (NCI) · withdrawn · Lymphoma, Diffuse Large-Cell B-cell, Diffuse, Large B-cell Lymphoma, Lymphoma, Diffuse Large-Cell · principal investigator
- Ph2NCT01030900 · Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin LymphomasNational Cancer Institute (NCI) · completed · Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma · principal investigator
- Ph2NCT00114738 · EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell LymphomaNational Cancer Institute (NCI) · completed · Lymphoma, Mantle Cell, Mantle Cell Lymphoma · principal investigator
- Ph2NCT00069238 · Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell LymphomasNational Cancer Institute (NCI) · completed · Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell · principal investigator
- Ph1NCT00022971 · Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI) · terminated · Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT00001563 · EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaNational Cancer Institute (NCI) · completed · AIDS Related Lymphoma, AIDS-Associated Lymphoma · principal investigator
- Ph2NCT00001586 · Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression AnalysisNational Cancer Institute (NCI) · completed · Chronic Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.